Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
- United Kingdom
Investment stages
- Seed
Industries
About
Syncona, a FTSE 250 healthcare company, creates, builds, and scales global leaders in life science to deliver transformational treatments and maximize value for stakeholders.
Syncona, a FTSE 250 healthcare company, creates, builds, and scales global leaders in life science to deliver transformational treatments and maximize value for stakeholders.
Investment Thesis
To invest in and build companies around exceptional science, focusing on delivering transformational treatments that extend and enhance human life.
Manager's Experience
With a robust background in private equity, the fund manager has successfully executed over 50 deals, primarily in the technology and healthcare sectors across North America and Europe. Emphasizing a thematic investment approach, they prioritize operator-first strategies that enhance portfolio performance. The manager's notable exits include several high-profile IPOs and acquisitions, demonstrating a strong track record in value creation. Their focus on early to growth-stage investments showcases a commitment to fostering innovation while delivering substantial returns.
Team
Stephen Molumby
Siobhan Weaver
Rolf Soderstrom
Michael Kyriakides
Kate Butler
Fergus Witt
Annabel Clay
Amisha Choksi